cd8 pe antibody Search Results


reafinitytm miltenyi 130 119 123 cd8a antibody  (Miltenyi Biotec)
95
Miltenyi Biotec reafinitytm miltenyi 130 119 123 cd8a antibody
Reafinitytm Miltenyi 130 119 123 Cd8a Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/reafinitytm miltenyi 130 119 123 cd8a antibody/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
reafinitytm miltenyi 130 119 123 cd8a antibody - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
anti cd8 pe abs  (R&D Systems)
95
R&D Systems anti cd8 pe abs
Anti Cd8 Pe Abs, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd8 pe abs/product/R&D Systems
Average 95 stars, based on 1 article reviews
anti cd8 pe abs - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
anti human cd8 ab  (Miltenyi Biotec)
96
Miltenyi Biotec anti human cd8 ab
Env-specific CD4+ T-cell and <t>CD8+</t> T-cell responses in 12 macaques. A: Env-specific CD8+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. B: Env-specific CD4+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. ELISPOT results are colored as follows: Δ5G SU-specific T cells (red), wt-SU-specific T cells (green), and TM-specific T cells (yellow). Arrows with a dotted line, arrows with broken line, and arrows with a solid line indicate the time of the third DNA vaccination at 8 weeks p.p., the time of the vaccine boost at 21 weeks p.p., and the time of SIVmac239 challenge at 28 weeks p.p., respectively. C: Comparison of SU-specific CD8+ T cells and CD4+ T cells in PBMCs among the wt-Env vaccine group, the Δ5G Env vaccine group, and the vector control group at 26 weeks p.p. and 4, 7, and 12 days p.i. The numbers of SFC responding to SIVmac239 SU were used to compare the effects of the two vaccines. w, weeks; d, days.
Anti Human Cd8 Ab, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human cd8 ab/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
anti human cd8 ab - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
anti mouse cd8 mab  (Miltenyi Biotec)
96
Miltenyi Biotec anti mouse cd8 mab
Env-specific CD4+ T-cell and <t>CD8+</t> T-cell responses in 12 macaques. A: Env-specific CD8+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. B: Env-specific CD4+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. ELISPOT results are colored as follows: Δ5G SU-specific T cells (red), wt-SU-specific T cells (green), and TM-specific T cells (yellow). Arrows with a dotted line, arrows with broken line, and arrows with a solid line indicate the time of the third DNA vaccination at 8 weeks p.p., the time of the vaccine boost at 21 weeks p.p., and the time of SIVmac239 challenge at 28 weeks p.p., respectively. C: Comparison of SU-specific CD8+ T cells and CD4+ T cells in PBMCs among the wt-Env vaccine group, the Δ5G Env vaccine group, and the vector control group at 26 weeks p.p. and 4, 7, and 12 days p.i. The numbers of SFC responding to SIVmac239 SU were used to compare the effects of the two vaccines. w, weeks; d, days.
Anti Mouse Cd8 Mab, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd8 mab/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
anti mouse cd8 mab - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
αcd8 pe  (Miltenyi Biotec)
96
Miltenyi Biotec αcd8 pe
Env-specific CD4+ T-cell and <t>CD8+</t> T-cell responses in 12 macaques. A: Env-specific CD8+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. B: Env-specific CD4+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. ELISPOT results are colored as follows: Δ5G SU-specific T cells (red), wt-SU-specific T cells (green), and TM-specific T cells (yellow). Arrows with a dotted line, arrows with broken line, and arrows with a solid line indicate the time of the third DNA vaccination at 8 weeks p.p., the time of the vaccine boost at 21 weeks p.p., and the time of SIVmac239 challenge at 28 weeks p.p., respectively. C: Comparison of SU-specific CD8+ T cells and CD4+ T cells in PBMCs among the wt-Env vaccine group, the Δ5G Env vaccine group, and the vector control group at 26 weeks p.p. and 4, 7, and 12 days p.i. The numbers of SFC responding to SIVmac239 SU were used to compare the effects of the two vaccines. w, weeks; d, days.
αcd8 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/αcd8 pe/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
αcd8 pe - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
anti cd8  (Miltenyi Biotec)
95
Miltenyi Biotec anti cd8
Env-specific CD4+ T-cell and <t>CD8+</t> T-cell responses in 12 macaques. A: Env-specific CD8+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. B: Env-specific CD4+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. ELISPOT results are colored as follows: Δ5G SU-specific T cells (red), wt-SU-specific T cells (green), and TM-specific T cells (yellow). Arrows with a dotted line, arrows with broken line, and arrows with a solid line indicate the time of the third DNA vaccination at 8 weeks p.p., the time of the vaccine boost at 21 weeks p.p., and the time of SIVmac239 challenge at 28 weeks p.p., respectively. C: Comparison of SU-specific CD8+ T cells and CD4+ T cells in PBMCs among the wt-Env vaccine group, the Δ5G Env vaccine group, and the vector control group at 26 weeks p.p. and 4, 7, and 12 days p.i. The numbers of SFC responding to SIVmac239 SU were used to compare the effects of the two vaccines. w, weeks; d, days.
Anti Cd8, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd8/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti cd8 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
anti cd8 pe  (Miltenyi Biotec)
95
Miltenyi Biotec anti cd8 pe
Env-specific CD4+ T-cell and <t>CD8+</t> T-cell responses in 12 macaques. A: Env-specific CD8+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. B: Env-specific CD4+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. ELISPOT results are colored as follows: Δ5G SU-specific T cells (red), wt-SU-specific T cells (green), and TM-specific T cells (yellow). Arrows with a dotted line, arrows with broken line, and arrows with a solid line indicate the time of the third DNA vaccination at 8 weeks p.p., the time of the vaccine boost at 21 weeks p.p., and the time of SIVmac239 challenge at 28 weeks p.p., respectively. C: Comparison of SU-specific CD8+ T cells and CD4+ T cells in PBMCs among the wt-Env vaccine group, the Δ5G Env vaccine group, and the vector control group at 26 weeks p.p. and 4, 7, and 12 days p.i. The numbers of SFC responding to SIVmac239 SU were used to compare the effects of the two vaccines. w, weeks; d, days.
Anti Cd8 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd8 pe/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti cd8 pe - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
cd8  (Miltenyi Biotec)
96
Miltenyi Biotec cd8
Env-specific CD4+ T-cell and <t>CD8+</t> T-cell responses in 12 macaques. A: Env-specific CD8+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. B: Env-specific CD4+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. ELISPOT results are colored as follows: Δ5G SU-specific T cells (red), wt-SU-specific T cells (green), and TM-specific T cells (yellow). Arrows with a dotted line, arrows with broken line, and arrows with a solid line indicate the time of the third DNA vaccination at 8 weeks p.p., the time of the vaccine boost at 21 weeks p.p., and the time of SIVmac239 challenge at 28 weeks p.p., respectively. C: Comparison of SU-specific CD8+ T cells and CD4+ T cells in PBMCs among the wt-Env vaccine group, the Δ5G Env vaccine group, and the vector control group at 26 weeks p.p. and 4, 7, and 12 days p.i. The numbers of SFC responding to SIVmac239 SU were used to compare the effects of the two vaccines. w, weeks; d, days.
Cd8, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
cd8 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
cd8 ecd pe vio615 miltenyi 130 123 914 rea802  (Miltenyi Biotec)
95
Miltenyi Biotec cd8 ecd pe vio615 miltenyi 130 123 914 rea802
Env-specific CD4+ T-cell and <t>CD8+</t> T-cell responses in 12 macaques. A: Env-specific CD8+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. B: Env-specific CD4+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. ELISPOT results are colored as follows: Δ5G SU-specific T cells (red), wt-SU-specific T cells (green), and TM-specific T cells (yellow). Arrows with a dotted line, arrows with broken line, and arrows with a solid line indicate the time of the third DNA vaccination at 8 weeks p.p., the time of the vaccine boost at 21 weeks p.p., and the time of SIVmac239 challenge at 28 weeks p.p., respectively. C: Comparison of SU-specific CD8+ T cells and CD4+ T cells in PBMCs among the wt-Env vaccine group, the Δ5G Env vaccine group, and the vector control group at 26 weeks p.p. and 4, 7, and 12 days p.i. The numbers of SFC responding to SIVmac239 SU were used to compare the effects of the two vaccines. w, weeks; d, days.
Cd8 Ecd Pe Vio615 Miltenyi 130 123 914 Rea802, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8 ecd pe vio615 miltenyi 130 123 914 rea802/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
cd8 ecd pe vio615 miltenyi 130 123 914 rea802 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
cd8 pe cy7  (R&D Systems)
95
R&D Systems cd8 pe cy7
In vivo suppression of T cell proliferation in male mice following a daily subcutaneous injection (for 7 days) of either (1) Normal Saline, (2) Empty PLGA NPs, (3) Prograf, or (4) TAC-loaded PLGA NPs. Flow cytometry analysis was conducted on two cell groups: ( A ) CD4 + T cells and ( B ) <t>CD8</t> + T cells (n = 6). The percentage of proliferating T cells is presented next to each gate. All samples are composed of the same number of acquired events (10 6 cells).
Cd8 Pe Cy7, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8 pe cy7/product/R&D Systems
Average 95 stars, based on 1 article reviews
cd8 pe cy7 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
sk1 anti human cd8b miltenyi biotec  (Miltenyi Biotec)
93
Miltenyi Biotec sk1 anti human cd8b miltenyi biotec
In vivo suppression of T cell proliferation in male mice following a daily subcutaneous injection (for 7 days) of either (1) Normal Saline, (2) Empty PLGA NPs, (3) Prograf, or (4) TAC-loaded PLGA NPs. Flow cytometry analysis was conducted on two cell groups: ( A ) CD4 + T cells and ( B ) <t>CD8</t> + T cells (n = 6). The percentage of proliferating T cells is presented next to each gate. All samples are composed of the same number of acquired events (10 6 cells).
Sk1 Anti Human Cd8b Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sk1 anti human cd8b miltenyi biotec/product/Miltenyi Biotec
Average 93 stars, based on 1 article reviews
sk1 anti human cd8b miltenyi biotec - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
cd8a pe vio770  (Miltenyi Biotec)
96
Miltenyi Biotec cd8a pe vio770
Changes in TIGIT expression on T cells in different tissues after T. gondii infection. (A) Proportions of TIGIT + cells among CD4 + and <t>CD8</t> + T cells in T. gondii- infected (RH) and normal mice (Nc) at 7 days after infection. (B) Results of statistical analysis of the percentage of TIGIT + cells among CD4 + T and CD8 + T cells in RH and Nc mice at 7 days after infection. (C) Dynamic changes in the percentages of TIGIT + in T cells at different time points. The results are representative of three independent experiments with five mice in each group per experiment, with data denoting means ± SDs.
Cd8a Pe Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd8a pe vio770/product/Miltenyi Biotec
Average 96 stars, based on 1 article reviews
cd8a pe vio770 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

Image Search Results


Env-specific CD4+ T-cell and CD8+ T-cell responses in 12 macaques. A: Env-specific CD8+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. B: Env-specific CD4+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. ELISPOT results are colored as follows: Δ5G SU-specific T cells (red), wt-SU-specific T cells (green), and TM-specific T cells (yellow). Arrows with a dotted line, arrows with broken line, and arrows with a solid line indicate the time of the third DNA vaccination at 8 weeks p.p., the time of the vaccine boost at 21 weeks p.p., and the time of SIVmac239 challenge at 28 weeks p.p., respectively. C: Comparison of SU-specific CD8+ T cells and CD4+ T cells in PBMCs among the wt-Env vaccine group, the Δ5G Env vaccine group, and the vector control group at 26 weeks p.p. and 4, 7, and 12 days p.i. The numbers of SFC responding to SIVmac239 SU were used to compare the effects of the two vaccines. w, weeks; d, days.

Journal:

Article Title: Influence of Glycosylation on the Efficacy of an Env-Based Vaccine against Simian Immunodeficiency Virus SIVmac239 in a Macaque AIDS Model

doi: 10.1128/JVI.79.16.10386-10396.2005

Figure Lengend Snippet: Env-specific CD4+ T-cell and CD8+ T-cell responses in 12 macaques. A: Env-specific CD8+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. B: Env-specific CD4+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. ELISPOT results are colored as follows: Δ5G SU-specific T cells (red), wt-SU-specific T cells (green), and TM-specific T cells (yellow). Arrows with a dotted line, arrows with broken line, and arrows with a solid line indicate the time of the third DNA vaccination at 8 weeks p.p., the time of the vaccine boost at 21 weeks p.p., and the time of SIVmac239 challenge at 28 weeks p.p., respectively. C: Comparison of SU-specific CD8+ T cells and CD4+ T cells in PBMCs among the wt-Env vaccine group, the Δ5G Env vaccine group, and the vector control group at 26 weeks p.p. and 4, 7, and 12 days p.i. The numbers of SFC responding to SIVmac239 SU were used to compare the effects of the two vaccines. w, weeks; d, days.

Article Snippet: PBMCs were subjected to the depletion of CD4 + cells with magnet beads coated with anti-human CD4 Ab (Dynal ASA, Oslo, Norway) or subjected to the depletion of CD8 + cells with magnet beads coated with anti-human CD8 Ab (Miltenyi Biotec, Bergisch Gladbach, Germany).

Techniques: Enzyme-linked Immunospot, Comparison, Plasmid Preparation, Vaccines

SIV-specific CD8+ T-cell and CD4+ T-cell responses in 12 animals. A: SIV viral-protein-specific CD8+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups: vector controls, wt-Env vaccine group, and Δ5G Env vaccines. B: SIV viral-protein-specific CD4+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. ELISPOT results of individual SIV proteins are colored as follows: Gag (red), Nef (green), Tat/Rev (blue), Vif/Vpr/Vpx (yellow), and Pol (pink). C: Comparison of cumulated CD8+ T cells or CD4+ T cells specific to the viral proteins Gag, Pol, Nef, Tat/Rev, and Vif/Vpr/VpX between SIV infection-controlled and uncontrolled animals. w, weeks; d, days.

Journal:

Article Title: Influence of Glycosylation on the Efficacy of an Env-Based Vaccine against Simian Immunodeficiency Virus SIVmac239 in a Macaque AIDS Model

doi: 10.1128/JVI.79.16.10386-10396.2005

Figure Lengend Snippet: SIV-specific CD8+ T-cell and CD4+ T-cell responses in 12 animals. A: SIV viral-protein-specific CD8+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups: vector controls, wt-Env vaccine group, and Δ5G Env vaccines. B: SIV viral-protein-specific CD4+ T cells in PBMCs were measured by ELISPOT assay for IFN-γ in three groups. ELISPOT results of individual SIV proteins are colored as follows: Gag (red), Nef (green), Tat/Rev (blue), Vif/Vpr/Vpx (yellow), and Pol (pink). C: Comparison of cumulated CD8+ T cells or CD4+ T cells specific to the viral proteins Gag, Pol, Nef, Tat/Rev, and Vif/Vpr/VpX between SIV infection-controlled and uncontrolled animals. w, weeks; d, days.

Article Snippet: PBMCs were subjected to the depletion of CD4 + cells with magnet beads coated with anti-human CD4 Ab (Dynal ASA, Oslo, Norway) or subjected to the depletion of CD8 + cells with magnet beads coated with anti-human CD8 Ab (Miltenyi Biotec, Bergisch Gladbach, Germany).

Techniques: Enzyme-linked Immunospot, Plasmid Preparation, Vaccines, Comparison, Infection

In vivo suppression of T cell proliferation in male mice following a daily subcutaneous injection (for 7 days) of either (1) Normal Saline, (2) Empty PLGA NPs, (3) Prograf, or (4) TAC-loaded PLGA NPs. Flow cytometry analysis was conducted on two cell groups: ( A ) CD4 + T cells and ( B ) CD8 + T cells (n = 6). The percentage of proliferating T cells is presented next to each gate. All samples are composed of the same number of acquired events (10 6 cells).

Journal: Scientific Reports

Article Title: Mitigation of Tacrolimus-Associated Nephrotoxicity by PLGA Nanoparticulate Delivery Following Multiple Dosing to Mice while Maintaining its Immunosuppressive Activity

doi: 10.1038/s41598-020-63767-1

Figure Lengend Snippet: In vivo suppression of T cell proliferation in male mice following a daily subcutaneous injection (for 7 days) of either (1) Normal Saline, (2) Empty PLGA NPs, (3) Prograf, or (4) TAC-loaded PLGA NPs. Flow cytometry analysis was conducted on two cell groups: ( A ) CD4 + T cells and ( B ) CD8 + T cells (n = 6). The percentage of proliferating T cells is presented next to each gate. All samples are composed of the same number of acquired events (10 6 cells).

Article Snippet: Standard surface staining protocol was followed for CD4 + and CD8 + T cells using anti-mouse CD4–APC (R&D systems) and CD8-PE-CY7 (R&D systems) monoclonal antibodies.

Techniques: In Vivo, Injection, Saline, Flow Cytometry

Changes in TIGIT expression on T cells in different tissues after T. gondii infection. (A) Proportions of TIGIT + cells among CD4 + and CD8 + T cells in T. gondii- infected (RH) and normal mice (Nc) at 7 days after infection. (B) Results of statistical analysis of the percentage of TIGIT + cells among CD4 + T and CD8 + T cells in RH and Nc mice at 7 days after infection. (C) Dynamic changes in the percentages of TIGIT + in T cells at different time points. The results are representative of three independent experiments with five mice in each group per experiment, with data denoting means ± SDs.

Journal: Parasite

Article Title: Expression of TIGIT in splenic and circulatory T cells from mice acutely infected with Toxoplasma gondii

doi: 10.1051/parasite/2021010

Figure Lengend Snippet: Changes in TIGIT expression on T cells in different tissues after T. gondii infection. (A) Proportions of TIGIT + cells among CD4 + and CD8 + T cells in T. gondii- infected (RH) and normal mice (Nc) at 7 days after infection. (B) Results of statistical analysis of the percentage of TIGIT + cells among CD4 + T and CD8 + T cells in RH and Nc mice at 7 days after infection. (C) Dynamic changes in the percentages of TIGIT + in T cells at different time points. The results are representative of three independent experiments with five mice in each group per experiment, with data denoting means ± SDs.

Article Snippet: The antibodies used were as follows: anti-mouse Abs against CD3ε-APC-Vio770, mouse (Miltenyi Biotec, 130-117-676), CD8a-PE-Vio770, mouse (Miltenyi Biotec, 130-102-358), PE/DazzleTM 594 anti-mouse CD4 Antibody (BioLegend, 100456), Brilliant Violet 421TM anti-mouse TIGIT (Vstm3) Antibody (BioLegend, 142111), Brilliant Violet 421TM Mouse IgG1, κ Isotype Ctrl Antibody (BioLegend, 400157), FITC anti-mouse CD226 (DNAM-1) (BioLegend, 128803), FITC Rat IgG2b, κ Isotype Ctrl Antibody (BioLegend, 400634), PE anti-mouse/human CD44 (BioLegend, 103007), and Alexa Fluor ® 488 anti-mouse CD62L Antibody (BioLegend, 104420).

Techniques: Expressing, Infection

Changes in CD226 expression on T cells in different tissues after T. gondii infection. (A) Proportions of CD226 + cells among CD4 + T and CD8 + T cells in T. gondii- infected (RH) and normal mice (Nc) at 7 days after infection. (B) Results of statistical analysis of the percentage of CD226 + cells among CD4 + T and CD8 + T in RH and Nc mice at 7 days after infection. (C) Dynamic changes in the percentages of CD226 + T cells at different time points. The results are representative of three independent experiments with five mice in each group per experiment, with data denoting means ± SDs.

Journal: Parasite

Article Title: Expression of TIGIT in splenic and circulatory T cells from mice acutely infected with Toxoplasma gondii

doi: 10.1051/parasite/2021010

Figure Lengend Snippet: Changes in CD226 expression on T cells in different tissues after T. gondii infection. (A) Proportions of CD226 + cells among CD4 + T and CD8 + T cells in T. gondii- infected (RH) and normal mice (Nc) at 7 days after infection. (B) Results of statistical analysis of the percentage of CD226 + cells among CD4 + T and CD8 + T in RH and Nc mice at 7 days after infection. (C) Dynamic changes in the percentages of CD226 + T cells at different time points. The results are representative of three independent experiments with five mice in each group per experiment, with data denoting means ± SDs.

Article Snippet: The antibodies used were as follows: anti-mouse Abs against CD3ε-APC-Vio770, mouse (Miltenyi Biotec, 130-117-676), CD8a-PE-Vio770, mouse (Miltenyi Biotec, 130-102-358), PE/DazzleTM 594 anti-mouse CD4 Antibody (BioLegend, 100456), Brilliant Violet 421TM anti-mouse TIGIT (Vstm3) Antibody (BioLegend, 142111), Brilliant Violet 421TM Mouse IgG1, κ Isotype Ctrl Antibody (BioLegend, 400157), FITC anti-mouse CD226 (DNAM-1) (BioLegend, 128803), FITC Rat IgG2b, κ Isotype Ctrl Antibody (BioLegend, 400634), PE anti-mouse/human CD44 (BioLegend, 103007), and Alexa Fluor ® 488 anti-mouse CD62L Antibody (BioLegend, 104420).

Techniques: Expressing, Infection